November 15, 2013 — Resverlogix Corp. announced two additional results from the ongoing analysis of its Phase 2b ASSURE ...
September 28, 2011 — A clinical trial by Resverlogix Corp. is evaluating the early effects of a new drug compound in ...
December 23, 2009 – The Cleveland Clinic this week initiated a phase II trial examining a new oral therapy for the ...
October 2, 2009 – Resverlogix Corp. said this week results from the company's second clinical trial for the drug RVX-208 ...